Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-25-105128

Options or other derivatives

  • President and CEO acquired 570,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Harris Todd President and CEO 2025-08-07 Grant or award · Stock Option (Right to Buy) +570,000 570,000 D
Loading xslF345X05/ownership.xml…